159 related articles for article (PubMed ID: 24824872)
1. Bortezomib induces apoptosis by interacting with JAK/STAT pathway in K562 leukemic cells.
Selvi N; Kaymaz BT; Gündüz C; Aktan C; Kiper HD; Sahin F; Cömert M; Selvi AF; Kosova B; Saydam G
Tumour Biol; 2014 Aug; 35(8):7861-70. PubMed ID: 24824872
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells.
Al-Rawashde FA; Wan Taib WR; Ismail I; Johan MF; Al-Wajeeh AS; Al-Jamal HAN
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3959-3965. PubMed ID: 34967577
[TBL] [Abstract][Full Text] [Related]
3. Methylprednisolone induces apoptosis by interacting with the JAK/STAT pathway in HL-60 and K-562 leukemic cells.
Kaymaz BT; Selvi N; Saydam G; Sahin F; Kosova B
Hematology; 2012 Mar; 17(2):93-9. PubMed ID: 22664047
[TBL] [Abstract][Full Text] [Related]
4. [Effects of arsenic trioxide combined with bortezomib on proliferation and apoptosis of K562 cells and their mechanism].
Wu HY; Wang SM; Huang JQ; Hao LM; Li XM; Wei LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1361-4. PubMed ID: 23257433
[TBL] [Abstract][Full Text] [Related]
5. Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis.
Kaymaz BT; Selvi N; Gündüz C; Aktan C; Dalmızrak A; Saydam G; Kosova B
Ann Hematol; 2013 Jan; 92(2):151-62. PubMed ID: 23053176
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.
Kaymaz BT; Cetintaş VB; Aktan C; Kosova B
Tumour Biol; 2014 Sep; 35(9):8733-42. PubMed ID: 24870597
[TBL] [Abstract][Full Text] [Related]
7. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms.
Dai Y; Rahmani M; Pei XY; Dent P; Grant S
Blood; 2004 Jul; 104(2):509-18. PubMed ID: 15039284
[TBL] [Abstract][Full Text] [Related]
9. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
[TBL] [Abstract][Full Text] [Related]
10. [Effect of bortezomib and arabinoside on proliferation and apoptosis of K562 cell.].
Lu SF; Lu Q
Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):42-5. PubMed ID: 20302779
[TBL] [Abstract][Full Text] [Related]
11. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and SHIP gene expression in K562 cells].
Jia ZQ; Wei YT; Li AM; Cheng ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):916-9. PubMed ID: 23998585
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of bortezomib-induced apoptosis by TGF-beta in cultured human Tenon's fibroblasts: contribution of the PI3K/Akt signaling pathway.
Chung EJ; Moon SW; Jung SA; Cho YJ; Kim SW; Lee JH
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6232-7. PubMed ID: 20702821
[TBL] [Abstract][Full Text] [Related]
13. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
Zhou RQ; Gong YP; Zheng BH; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
[TBL] [Abstract][Full Text] [Related]
14. [Effects of bortezomib combined with 5-azacytidine on the apoptosis of K562 cells and expression of SHIP mRNA].
Jia ZQ; Wei YT; Wei YL; Su W; Yu CX; Tao J; Rong HQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1291-4. PubMed ID: 25338575
[TBL] [Abstract][Full Text] [Related]
15. [Effect of bortezomib on the drug sensitivity of imatinib resistant K562/G01 cells].
Zhou Y; Ma LM; Li XY; Zhang HP; Wang T; Niu YY; Ren RR
Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):392-5. PubMed ID: 21781497
[TBL] [Abstract][Full Text] [Related]
16. Enalapril-induced apoptosis of acute promyelocytic leukaemia cells involves STAT5A.
Purclutepe O; Iskender G; Kiper HD; Tezcanli B; Selvi N; Avci CB; Kosova B; Gokbulut AA; Sahin F; Baran Y; Saydam G
Anticancer Res; 2012 Jul; 32(7):2885-93. PubMed ID: 22753752
[TBL] [Abstract][Full Text] [Related]
17. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and XIAP expression in K562 cells].
Shao M; Sun L; Cui XY; Han XF; Chen SM; Wang F; Zhang H; Ling Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):182-6. PubMed ID: 21535957
[TBL] [Abstract][Full Text] [Related]
18. Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells.
Liu CY; Shiau CW; Kuo HY; Huang HP; Chen MH; Tzeng CH; Chen KF
Haematologica; 2013 May; 98(5):729-38. PubMed ID: 22983581
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Role of JAK/STAT Pathway on Dasatinib-Induced Apoptosis for CML Cell Model K562.
Dalgıç CT; Kaymaz BT; Özkan MC; Dalmızrak A; Şahin F; Saydam G
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S161-6. PubMed ID: 26297271
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism associated to enhancing the sensitivity of myeloma cells U266 to bortezomib by 2-methoxyestradiol].
Wu SQ; Xu ZZ; Huang HB; Lin J; Zhan R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1424-8. PubMed ID: 22169296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]